SCHEMBL9890083

SCHEMBL9890083

Cc1ccc2oc3cc4c(cc3c2c1)oc1ccc(-n2c3ccccc3c3ccccc32)cc14

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ATM Q13315 1/20 0.41
ALDH1A1 P00352 6/20 0.38
MAPT P10636 4/20 0.38
HPGD P15428 3/20 0.38
HSD17B10 Q99714 2/20 0.38
TP53 P04637 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAOA P21397 1/20 0.36
HTT P42858 2/20 0.36
LMNA P02545 3/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
PPARG P37231 2/20 0.36
RXFP1 Q9HBX9 2/20 0.36
NR2E3 Q9Y5X4 2/20 0.36
NCOR2 Q9Y618 2/20 0.36
AHR P35869 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10144804 0.97 KDM4E (0.43) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL9890328 0.96 MAOA (0.41) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL17993385 0.94 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL17850761 0.94 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL16920067 0.92 ALDH1A1 (0.41) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL15785780 0.92 ALDH1A1 (0.41) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL9890525 0.91 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL20115828 0.91 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL17636095 0.91 KDM4E (0.41) KDM4EL3MBTL1ATMALDH1A1MAPT
SCHEMBL9890074 0.91 KDM4E (0.48) KDM4EL3MBTL1ATMALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2013-01-24 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-8318323-B2 Polycyclic compounds and organic electroluminescence device employing the same IDEMITSU KOSAN CO., LTD. (JP) 2012-11-27 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 US disclosed
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2010-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130020563-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 KDM4E 990/4885L3MBTL1 709/4885ATM 3103/4885
US-20100012931-A1 POLYCYCLIC COMPOUNDS AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME KCNC1, EED, BMI1 KDM4E 990/4885L3MBTL1 709/4885ATM 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.